By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667



Company News
Adaptive Biotechnologies And Researchers From MD Anderson Cancer Center Demonstrate Ability To Detect Hodgkin's Lymphoma In Blood 4/28/2015 7:44:54 AM
Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Detects Relapse With Higher Specificity Than PET/CT In Diffuse Large B-Cell Lymphoma Patients 4/22/2015 11:20:18 AM
Adaptive Biotechnologies And Collaborators To Present 4 Studies Demonstrating Clinical Relevance Of Immunosequencing In The Treatment Of Solid Tumors At The 2015 American Association for Cancer Research Annual Meeting 4/15/2015 8:17:00 AM
Multiple Myeloma Research Foundation (MMRF), University Of Torino, And Adaptive Biotechnologies Work To Speed Novel Minimal Residual Disease Monitoring Technologies To Patients 4/14/2015 8:06:11 AM
Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse In Diffuse Large B-Cell Lymphoma Patients By Sensitively Detecting Circulating Tumor DNA 4/2/2015 6:37:54 AM
Adaptive Biotechnologies Invited To Present At Upcoming Conferences 3/17/2015 11:09:39 AM
Adaptive Biotechnologies Adds Chad Cohen, Zillow Group CFO, To Board Of Directors 3/3/2015 11:24:31 AM
Adaptive Biotechnologies CEO To Present And Join Distinguished Panel At 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 9:57:15 AM
Adaptive Biotechnologies Banks $94 Million, Buys Bay Area's Sequenta, Inc. 1/8/2015 6:42:42 AM
Adaptive Biotechnologies Announces Acquisition Of Sequenta, Inc. 1/7/2015 11:02:12 AM